Searching for Disease-Modifying Drugs in AD: Can We Combine Neuropsychological Tools with Biological Markers?

E-ISSN： 1996-3181|13|1|173-186

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.1, 2014-02, pp. : 173-186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Clinical and Economic Review of Disease-Modifying Antirheumatic Drugs

By Gabriel S.E.

PharmacoEconomics, Vol. 19, Iss. 7, 2001-07 ,pp. : 715-728

Adis International

Access to resources Recommend Favorite

Monitoring and Assessing the Safety of Disease-Modifying Antirheumatic Drugs: A West Midlands Experience

By Jobanputra P. Maggs F. Homer D. Bevan J.

Drug Safety, Vol. 25, Iss. 15, 2002-01 ,pp. : 1099-1105

Adis International

Access to resources Recommend Favorite

Disease-Modifying Antirheumatic Drugs: Using Their Clinical Pharmacological Effects As a Guide to Their Selection

By Jackson C.G.

Drugs, Vol. 56, Iss. 3, 1998-09 ,pp. : 337-344

Adis International

Access to resources Recommend Favorite

Disease-Modifying Antirheumatic Drugs in Pregnancy: Current Status and Implications for the Future

By Vroom Fokaline

Drug Safety, Vol. 29, Iss. 10, 2006-01 ,pp. : 845-863

Adis International

Access to resources Recommend Favorite

Clinically Important Drug Interactions with Disease-Modifying Antirheumatic Drugs

By Haagsma C.J.

Drugs & Aging, Vol. 13, Iss. 4, 1998-10 ,pp. : 281-289

Adis International

Access to resources Recommend Favorite